Heat shock protein-related diagnostic signature and molecular subtypes in ankylosing spondylitis: new pathogenesis insights

References

• Hanson A, Brown MA. Genetics and the causes of ankylosing spondylitis. Rheum Dis Clin North Am. 2017;43(3):1–12. doi: 10.1016/j.rdc.2017.04.006.
   PubMed Web of Science ®Google Scholar
• Mauro D, Thomas R, Guggino G, et al. Ankylosing spondylitis: an autoimmune or autoinflammatory disease? Nat Rev Rheumatol. 2021;17(7):387–404. doi: 10.1038/s41584-021-00625-y.
   PubMed Web of Science ®Google Scholar
• Bond D. Ankylosing spondylitis: diagnosis and management. Nurs Stand. 2013;28(16-18):52–59; quiz 60. doi: 10.7748/ns2013.12.28.16.52.e7807.
   PubMedGoogle Scholar
• Chen B, Li J, He C, et al. Role of HLA-B27 in the pathogenesis of ankylosing spondylitis (review). Mol Med Rep. 2017;15(4):1943–1951. doi: 10.3892/mmr.2017.6248.
   PubMed Web of Science ®Google Scholar
• Khan MA, Yong SB, Wei JC. Ankylosing spondylitis: history, epidemiology, and HLA-B27. Int J Rheum Dis. 2023;26(3):413–414. doi: 10.1111/1756-185X.14547.
   PubMed Web of Science ®Google Scholar
• Pedersen OB, Svendsen AJ, Ejstrup L, et al. Ankylosing spondylitis in Danish and Norwegian twins: occurrence and the relative importance of genetic vs. environmental effectors in disease causation. Scand J Rheumatol. 2008;37(2):120–126. doi: 10.1080/03009740701824613.
   PubMed Web of Science ®Google Scholar
• Liao HT, Tsai CY, Lai CC, et al. The potential role of genetics, environmental factors, and gut dysbiosis in the aberrant non-coding RNA expression to mediate inflammation and osteoclastogenic/osteogenic differentiation in ankylosing spondylitis. Front Cell Dev Biol. 2021;9:748063. doi: 10.3389/fcell.2021.748063.
   PubMed Web of Science ®Google Scholar
• Zininga T, Ramatsui L, Shonhai A. Heat shock proteins as immunomodulants. Molecules. 2018;23(11):2846. doi: 10.3390/molecules23112846.
   PubMed Web of Science ®Google Scholar
• Keijzer C, Wieten L, van Herwijnen M, et al. Heat shock proteins are therapeutic targets in autoimmune diseases and other chronic inflammatory conditions. Expert Opin Ther Targets. 2012;16(9):849–857. doi: 10.1517/14728222.2012.706605.
   PubMed Web of Science ®Google Scholar
• Tukaj S, Zillikens D, Kasperkiewicz M. Heat shock protein 90: a pathophysiological factor and novel treatment target in autoimmune bullous skin diseases. Exp Dermatol. 2015;24(8):567–571. doi: 10.1111/exd.12760.
   PubMed Web of Science ®Google Scholar
• Spierings J, van Eden W. Heat shock proteins and their immunomodulatory role in inflammatory arthritis. Rheumatol. 2017;56(2):198–208. doi: 10.1093/rheumatology/kew266.
   PubMed Web of Science ®Google Scholar
• Fouani M, Basset CA, Mangano GD, et al. Heat shock proteins alterations in rheumatoid arthritis. Int J Mol Sci. 2022;23(5):2806. doi: 10.3390/ijms23052806.
   PubMed Web of Science ®Google Scholar
• Ulmansky R, Landstein D, Moallem E, et al. A humanized monoclonal antibody against heat shock protein 60 suppresses murine arthritis and colitis and skews the cytokine balance toward an anti-inflammatory response. J Immunol. 2015;194(11):5103–5109. doi: 10.4049/jimmunol.1500023.
   PubMed Web of Science ®Google Scholar
• Lorenzo N, Barberá A, Domínguez MC, et al. Therapeutic effect of an altered peptide ligand derived from heat-shock protein 60 by suppressing of inflammatory cytokines secretion in two animal models of rheumatoid arthritis. Autoimmunity. 2012;45(6):449–459. doi: 10.3109/08916934.2012.697592.
   PubMed Web of Science ®Google Scholar
• Klimczak M, Biecek P, Zylicz A, et al. Heat shock proteins create a signature to predict the clinical outcome in breast cancer. Sci Rep. 2019;9(1):7507. doi: 10.1038/s41598-019-43556-1.
   PubMedGoogle Scholar
• Tong Q, Zhou J. Construction of a 12-gene prognostic model for colorectal cancer based on heat shock protein-related genes. Int J Hyperthermia. 2024;41(1):2290913. doi: 10.1080/02656736.2023.2290913.
   PubMed Web of Science ®Google Scholar
• Aran D, Hu Z, Butte AJ. xCell: digitally portraying the tissue cellular heterogeneity landscape. Genome Biol. 2017;18(1):220. doi: 10.1186/s13059-017-1349-1.
   PubMed Web of Science ®Google Scholar
• Taurog JD, Chhabra A, Colbert RA. Ankylosing spondylitis and axial spondyloarthritis. N Engl J Med. 2016;374(26):2563–2574. doi: 10.1056/NEJMra1406182.
   PubMed Web of Science ®Google Scholar
• Gomez CR. Role of heat shock proteins in aging and chronic inflammatory diseases. Geroscience. 2021;43(5):2515–2532. doi: 10.1007/s11357-021-00394-2.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Klionsky DJ. CCT2, a newly identified aggrephagy receptor in mammals, specifically mediates the autophagic clearance of solid protein aggregates. Autophagy. 2022;18(7):1483–1485. doi: 10.1080/15548627.2022.2083305.
   PubMed Web of Science ®Google Scholar
• Lv W, Shi L, Pan J, et al. Comprehensive prognostic and immunological analysis of CCT2 in pan-cancer. Front Oncol. 2022;12:986990. doi: 10.3389/fonc.2022.986990.
   PubMedGoogle Scholar
• Song B, Shen S, Fu S, et al. HSPA6 and its role in cancers and other diseases. Mol Biol Rep. 2022;49(11):10565–10577. doi: 10.1007/s11033-022-07641-5.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhuo HQ, Hong ZJ, et al. HSPA6, a novel prognostic and therapeutic biomarker, associated with ming classification in gastric cancer. J Clin Lab Anal. 2023;37(1):e24763. doi: 10.1002/jcla.24763.
   PubMed Web of Science ®Google Scholar
• Sopha P, Meerod T, Chantrathonkul B, et al. Novel functions of the ER-located Hsp40s DNAJB12 and DNAJB14 on proteins at the outer mitochondrial membrane under stress mediated by CCCP. Mol Cell Biochem. 2023 Oct 18. doi: 10.1007/s11010-023-04866-1.
   PubMed Web of Science ®Google Scholar
• Nieto-González JL, Gómez-Sánchez L, Mavillard F, et al. Loss of postnatal quiescence of neural stem cells through mTOR activation upon genetic removal of cysteine string protein-α. Proc Natl Acad Sci U S A. 2019;116(16):8000–8009. doi: 10.1073/pnas.1817183116.
   PubMed Web of Science ®Google Scholar
• Lopez-Ortega E, Ruiz R, Tabares L. CSPα, a molecular co-chaperone essential for short and Long-Term synaptic maintenance. Front Neurosci. 2017;11:39. doi: 10.3389/fnins.2017.00039.
   PubMed Web of Science ®Google Scholar
• Wang H, Luo J, Tian X, et al. DNAJC5 promotes hepatocellular carcinoma cells proliferation though regulating SKP2 mediated p27 degradation. Biochim Biophys Acta Mol Cell Res. 2021;1868(6):118994. doi: 10.1016/j.bbamcr.2021.118994.
   PubMed Web of Science ®Google Scholar
• Roosen DA, Blauwendraat C, Cookson MR, et al. DNAJC proteins and pathways to parkinsonism. Febs J. 2019;286(16):3080–3094. doi: 10.1111/febs.14936.
   PubMed Web of Science ®Google Scholar
• Raychaudhuri SP, Deodhar A. The classification and diagnostic criteria of ankylosing spondylitis. J Autoimmun. 2014;48-49:128–133. doi: 10.1016/j.jaut.2014.01.015.
   PubMed Web of Science ®Google Scholar
• Wu J, Yan L, Chai K. Systemic immune-inflammation index is associated with disease activity in patients with ankylosing spondylitis. J Clin Lab Anal. 2021;35(9):e23964. doi: 10.1002/jcla.23964.
   PubMed Web of Science ®Google Scholar
• Rezaiemanesh A, Abdolmaleki M, Abdolmohammadi K, et al. Immune cells involved in the pathogenesis of ankylosing spondylitis. Biomed Pharmacother. 2018;100:198–204. doi: 10.1016/j.biopha.2018.01.108.
   PubMed Web of Science ®Google Scholar
• Han Y, Zhou Y, Li H, et al. Identification of diagnostic mRNA biomarkers in whole blood for ankylosing spondylitis using WGCNA and machine learning feature selection. Front Immunol. 2022;13:956027. doi: 10.3389/fimmu.2022.956027.
   PubMed Web of Science ®Google Scholar
• Yang M, Lv Q, Wei Q, et al. TNF-α inhibitor therapy can improve the immune imbalance of CD4+ T cells and negative regulatory cells but not CD8+ T cells in ankylosing spondylitis. Arthritis Res Ther. 2020;22(1):149. doi: 10.1186/s13075-020-02226-8.
   PubMed Web of Science ®Google Scholar